Navigation Links
Veran Medical Technologies Launches New SPiN Drive™ Application for Bi-Planar Virtual Fluoroscopy View

ST. LOUIS, Dec. 16, 2011 /PRNewswire/ -- Veran Medical Technologies announced today the release of its SPiN Drive™ platform upgrade for bi-planar virtual fluoroscopy view used to navigate multiple planes simultaneously. This advancement is the first of its kind in pulmonology, enabling physicians to view the location of the Always-On Tip Tracked™ instrument in a fluoro-like view without any radiation being delivered to the patient, physician or staff.


"The significance of targeting Solitary Pulmonary Nodules (SPNs) without radiation is exciting," said Alexander C. Chen, M.D., of Washington University, St. Louis, MO. "The virtual fluoroscopic view provides images that the majority of bronchoscopists utilize while targeting solitary pulmonary nodules, without the radiation exposure. Additionally, the ability to map airways during procedures may provide a significant advantage towards targeting SPNs."

"This enhancement is ground-breaking technology," said Mark Hunter, vice president of strategic operations at Veran Medical Technologies. "Auto-rotate fly-through view makes instrument steering more intuitive and consistent with the user's standard bronchoscopic view."

Lung cancer is a deadly disease that mortally claims 85 percent of patients within five years. Diagnosing lung cancer at Stage I improves survival chances significantly. Due to the 69 million CT scans that occur annually in the United States, inadvertent lung cancer screening is occurring. However, SPNs in the peripheral lung are inaccessible with today's techniques and technologies, leaving patients on "watchful waiting" protocols of repeat CT scanning causing significant patient anxiety and unproductive costs added to the U.S. healthcare system. Veran's SPiN Drive™ product acts as a GPS-like system to enable pulmonologists and surgeons to access SPNs and immediately diagnose malignancy, end watchful waiting and reduce healthcare spending.

About Veran Medical Technologies, Inc.

Veran Medical Technologies is a privately held company led by a team of innovators focused on developing the next standard of care for minimally invasive delivery of interventional oncology therapies. Veran has built several clinical products upon its ig4™ platform technology, which uses proprietary 4D registration capabilities for targeting lesions within the human body. The company believes that by enabling minimally invasive early stage treatments, it can increase patient survival and lower healthcare costs significantly. Veran Medical Technologies is headquartered in St. Louis, MO.

SOURCE Veran Medical Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Veran Medical Receives FDA Clearance to Market Electromagnetic Navigated Bronchoscopy Product: The SPiN Drive(TM) System
2. VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System
3. Saladax Biomedical, Inc. Expands Distribution of My5-FU in Europe
4. MD+DI, the Global MedTech Industry Authority, Highlights the Human Element in Medical Device Design: Designing the Devices Surgeons Want and Pushing the Boundaries of Innovation
5. Dehaier Medical Enters European Homecare Medical Product Market
6. Kensey Nash to Enter Into Mediation with St. Jude Medical over Angio-Seal Contract Disputes
7. Concord Medical to Present at the 30th Annual J.P. Morgan Healthcare Conference in January 2012
8. Medical Device Costa Rica: An MPO Symposium Helps Firms Connect, Learn & Master Global Manufacturing Skills
9. TransTech Medical Solutions Ranked #1 by KLAS for 2011
10. FDA, Austen BioInnovation Institute to Collaborate on the Safety and Performance of Materials used in Medical Devices
11. MedShape, Inc. Awarded U.S. Patent for Deploying Shape Memory Polymer Devices in Medical Applications
Post Your Comments:
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... recently ... of Eyeglasses . , Millions of individuals in the United States and Canada ... become a way to both correct vision and make a fashion statement. Even celebrities ...
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
Breaking Medicine News(10 mins):